ProSomnus: ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

PLEASANTON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy , announced that it has contributed two scientific abstracts that have been accepted for presentation at SLEEP 2024, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, June 1-5 in Houston, TX.Abstract ID 1262"Evaluating the Clinical Performance of a Novel, Precision Oral Appliance Therapy Medical Device Made Wholly from a Medical Grade Class VI Material for the Treatment of Obstructive Sleep Apnea"E Sall1; K Smith2; A Desai3; JA Carollo4; MT Murphy5; S Kim6; LA Liptak61GoTo Sleep Center, Glendale, AZ2Star Sleep & Wellness, Frisco, TX3London Bridge Hospital, London, GBR4Dental Sleep Medicine of New Jersey, Florham Park, NJ5Funktional Sleep, Rochester Hills, MI6ProSomnus Sleep Technologies, Pleasanton, CAThis study evaluated the clinical performance of a novel, precision oral appliance therapy (ProSomnus OAT) medical device made entirely from a US Pharmacopeia (USP) medical grade class VI ...Full story available on Benzinga.com